Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kaushal Kumar Dwivedi"'
Publikováno v:
Biomedical and Biotechnology Research Journal, Vol 3, Iss 2, Pp 87-91 (2019)
Background: Multidrug-resistant tuberculosis (MDR-TB) is a threat to the accomplishments of the World Health Organization's (WHO) End TB Strategy. The treatment of MDR-TB is less effective and more toxic; additional resistance to second-line drugs ma
Externí odkaz:
https://doaj.org/article/8d2a4c9be1294bd79e662ec400d87f50
Autor:
Srashty Sharma, M Hanif, Kamal Kishore Chopra, Mukesh Sharma, Kaushal Kumar Dwivedi, Zeeshan Sidiq, Himanshu Vashistha, Vasim Ahmed, Manoj Dubey
Publikováno v:
Biomedical and Biotechnology Research Journal, Vol 2, Iss 2, Pp 132-135 (2018)
Background: Extrapulmonary tuberculosis (EPTB) constitutes about 15%–20% of all cases of TB. Patients with EPTB are more likely to have negative sputum smear results. It is often hard to diagnose because of difficulty of sampling and paucibacillary
Externí odkaz:
https://doaj.org/article/760a8a5cd3f447e480bd1ebeec3eed9e
Autor:
Zeeshan Sidiq, M. Hanif, Kaushal Kumar Dwivedi, Kamal Kishore Chopra, Ashwani Khanna, B.K. Vashishat
Publikováno v:
Indian Journal of Tuberculosis.
Publikováno v:
Indian Journal of Tuberculosis
The Indian Journal of Tuberculosis
The Indian Journal of Tuberculosis
In December 2019 a novel coronavirus SARS-CoV-2 emerged in the Hunan seafood market in Wuhan, China, and soon became a global health problem. Since its outbreak, SARS-CoV-2 has had a major impact on clinical diagnostic laboratories. The scientific co
Publikováno v:
Indian Journal of Tuberculosis. 67:S61-S68
The laboratory plays an important role in diagnosing tuberculosis (TB) and the identification and drug sensitivity testing (DST) of Mycobacterium tuberculosis. With a timely diagnosis and treatment with appropriate anti-TB drugs, most people who deve
Publikováno v:
The Indian Journal of Tuberculosis
Indian Journal of Tuberculosis
Indian Journal of Tuberculosis
Accurate and rapid diagnostic tests are critical for achieving control of coronavirus disease 2019 (covid-19), a pandemic illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Diagnostic tests for covid-19 fall into two main
Publikováno v:
The Indian journal of tuberculosis. 69(4)
Background Globally, EPTB accounts for 15% of the notified incident TB cases. Laboratory confirmation of EPTB is challenging and majority of the cases remain undetected for a longer time. A major breakthrough in the diagnosis of EPTB was the introduc
Autor:
Kaushal Kumar Dwivedi, Ashwani Khanna, Indrani Jadhav, Zeeshan Sidiq, Kanwaljit Chopra, M. Hanif
Publikováno v:
Biomedical and Biotechnology Research Journal, Vol 3, Iss 2, Pp 87-91 (2019)
Background: Multidrug-resistant tuberculosis (MDR-TB) is a threat to the accomplishments of the World Health Organization's (WHO) End TB Strategy. The treatment of MDR-TB is less effective and more toxic; additional resistance to second-line drugs ma
Autor:
Kaushal Kumar Dwivedi, Mukesh Sharma, K K Chopra, Zeeshan Sidiq, M. Hanif, Vasim Ahmed, Himanshu Vashistha, Srashty Sharma, Manoj Dubey
Publikováno v:
Biomedical and Biotechnology Research Journal, Vol 2, Iss 2, Pp 132-135 (2018)
Background: Extrapulmonary tuberculosis (EPTB) constitutes about 15%–20% of all cases of TB. Patients with EPTB are more likely to have negative sputum smear results. It is often hard to diagnose because of difficulty of sampling and paucibacillary
Publikováno v:
Journal of Biotechnology & Biomaterials.
Tuberculosis (TB) caused by Mycobacterium tuberculosis has been identified as a remerging infectious disease with public health importance globally. Exploitation of better diagnosis techniques for precise isolation of mycobacteria in clinical specime